CARL ZEISS MEDITEC’S NEAR-TERM OUTLOOK DIMS (SELL; 11% DOWNSIDE)
16/11/20 -"At the start of 2020, Carl Zeiss Meditec/CZM (Sell, Germany) was trading at its life-time high levels as the FY 18/19 (ending September 2019) sales growth and operating margin hit record highs – ..."
Pages
60
Language
English
Published on
16/11/20
You may also be interested by these reports :
04/02/26
The FY25 performance was in line with expectations, with 7.6% revenue growth and 170bps margin expansion driven by BPS strength, improved mix, and ...
03/02/26
Sartorius Stedim’s operations recovered well in FY25, driven primarily by high-margin consumables. Positive volume and mix effects expanded ...
03/02/26
Demant’s 2025 figures slightly exceeded estimates, driven by growth in Hearing Care and Diagnostics, particularly towards the year-end. However, ...
28/01/26
Getinge reported a soft Q4, with net sales and adjusted EBITA missing expectations and organic growth slowing to 1.2%. Order momentum also eased, ...